English NewsSunday, 15 November 2026
Latest
Medical

How do GLP-1 drugs work? Understanding GLP-1s for diabetes, weight loss, and beyond

2026-02-11

How do GLP-1 drugs work? Understanding GLP-1s for diabetes, weight loss, and beyond
Photo: cogdogblog (CC BY-2.0)

GLP-1 receptor agonists have drawn enormous attention for treating type 2 diabetes and driving weight loss. Their benefits are well established, but they also carry potential risks and side effects.

How do GLP-1 drugs work?

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that imitate the natural GLP-1 hormone, which helps regulate blood sugar and appetite. A related drug, tirzepatide, mimics GLP-1 as well as a second hormone, glucose-dependent insulinotropic polypeptide (GIP). Most GLP-1 medicines are injected into the abdomen, thigh, or upper arm.

How do GLP-1s help manage diabetes?

For people with type 2 diabetes, keeping blood sugar in check is essential to preventing complications such as nerve damage, kidney disease and heart problems. GLP-1 receptor agonists - including semaglutide, liraglutide and tirzepatide - help by boosting insulin secretion in response to meals, which lowers blood sugar. They also reduce glucagon, a hormone that pushes blood sugar up.

Unlike insulin, which acts whatever your glucose level, GLP-1 drugs lower blood sugar only when it is high. This glucose-dependent action reduces the risk of dangerously low blood sugar (hypoglycemia), making them a safer choice than some other diabetes treatments.

GLP-1 receptor agonists also lower the likelihood of heart attacks and strokes - an important point, since diabetes itself raises cardiovascular risk.

How do GLP-1s support weight loss?

Much of the excitement around these drugs comes from their effect on weight. They slow the emptying of the stomach so you feel full for longer, and they signal the brain to increase feelings of fullness, which reduces how much you eat.

For obesity, GLP-1s are generally prescribed at higher doses than for diabetes. Liraglutide, semaglutide and tirzepatide all have FDA approval for weight loss.

In some studies, people taking GLP-1s lost an average of 10% to 15% of their body weight over a year, and the most effective of these drugs can produce losses above 20%. That matters because even a 5% to 10% reduction improves metabolic health, lowers blood pressure, and cuts the risk of conditions like fatty liver disease and obstructive sleep apnea.

Side effects you may experience

As with any medication, GLP-1 receptor agonists can cause side effects, which often ease as the body adjusts. To keep them to a minimum, doctors usually start with a low dose and raise it gradually. The most common side effects include:

Nausea

Vomiting

Diarrhea

Constipation

Abdominal discomfort

Less common possibilities are headaches, a faster heart rate, dizziness and fatigue, along with mild injection-site reactions such as redness or itching.

Specialists note a common misconception that everyone suffers major side effects. In practice, gastrointestinal complaints like nausea and constipation are frequent but usually temporary and manageable.

Possible risks of GLP-1s

These drugs are generally considered safe, yet they are not risk-free. Ongoing nausea or vomiting can occasionally lead to dehydration, kidney problems, or malnutrition. People with serious gastrointestinal conditions - gastroparesis or uncontrolled inflammatory bowel disease, for example - should not take them, and they are not considered safe during pregnancy or breastfeeding.

Other risks include:

Pancreatitis

Gallbladder problems

Thyroid tumors

Muscle loss

If you are taking a GLP-1 or thinking about it, talk these risks over with your doctor; some can be mitigated - your doctor might suggest raising your protein intake to guard against muscle loss, for instance.

Be wary of compounded GLP-1 products, which surged in popularity during the drug shortage that began in 2022. The FDA has warned about them following reports of harmful effects, and compounded drugs are not checked by the FDA for safety, effectiveness, or quality.

Potential benefits under investigation

Researchers are probing uses for GLP-1 drugs beyond diabetes and weight loss. Major areas of study include:

Heart health

Brain health

Addiction treatment

Liver disease

Sleep apnea

Specialists say the most striking benefits for patients with diabetes or obesity remain substantial weight loss, reduced appetite and better blood sugar control.

More Medical news